ResearcherJinan UniversityActive in the last 2 years

Mingyi Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8438-3894; OpenAlex author ID A5101862692. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

REEP3 is a potential diagnostic and prognostic biomarker correlated with immune infiltration in pancreatic cancer. Last author DOI 10.1038/s41598-024-64720-2 ↗
Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/cam4.2818 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Guo-Hua Liu · 1 shared paper, 2024 · strength 0.24
- Paper REEP3 is a potential diagnostic and prognostic biomarker correlated with immune infiltration in pancreatic cancer. DOI 10.1038/s41598-024-64720-2 ↗
Xiao‐Guang Liu · 1 shared paper, 2020 · strength 0.09
- Paper Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early s… DOI 10.1002/cam4.2818 ↗
Xiwen Liao · 1 shared paper, 2020 · strength 0.09
- Paper Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early s… DOI 10.1002/cam4.2818 ↗
Nianping Chen · 1 shared paper, 2020 · strength 0.09
- Paper Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early s… DOI 10.1002/cam4.2818 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.